▶ 調査レポート

ソマトスタチンアナログの世界市場:インサイト・予測

• 英文タイトル:Global Somatostatin Analogs Market Insights, Forecast to 2025

QYResearchが調査・発行した産業分析レポートです。ソマトスタチンアナログの世界市場:インサイト・予測 / Global Somatostatin Analogs Market Insights, Forecast to 2025 / QYR9ST01187資料のイメージです。• レポートコード:QYR9ST01187
• 出版社/出版日:QYResearch / 2019年9月2日
※2024年版があります。お問い合わせください。

• レポート形態:英文、PDF、115ページ
• 納品方法:Eメール(受注後2-3営業日)
• 産業分類:医薬品・医療
• 販売価格(消費税別)
  Single User¥577,200 (USD3,900)▷ お問い合わせ
  Enterprise License¥1,154,400 (USD7,800)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
※本調査レポートでは、世界のソマトスタチンアナログ市場について調査・分析し、以下の構成でお届け致します。ソマトスタチンアナログの種類別には、オクトレオチド、ランレオチド、パシレオチドに、用途別には、先端巨大症、カルチノイド症候群、神経内分泌腫瘍、クッシング症候群、その他に、地域別には、北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカなどに区分してセグメント分析を行いました。

・調査販売
・エグゼクティブ・サマリー
・企業別ソマトスタチンアナログ売上データ
・地域別ソマトスタチンアナログ市場規模:北米、アメリカ、ヨーロッパ、アジア、中国、日本国内、韓国、インド、中南米、中東・アフリカ、その他
・種類別ソマトスタチンアナログ市場規模:オクトレオチド、ランレオチド、パシレオチド
・用途別ソマトスタチンアナログ市場規模:先端巨大症、カルチノイド症候群、神経内分泌腫瘍、クッシング症候群、その他
・主要メーカーの企業情報:Novartis、Peptron、Chiasma、Ipsen Biopharmaceutical
・ソマトスタチンアナログの市場規模予測
・バリューチェーン及び販売チャネル分析
・市場機会・課題・リスク・影響因子分析
...

Somatostatin analogues stop your body from making too many hormones. They can reduce the symptoms of carcinoid syndrome and may slow down tumour growth.Somatostatin is a protein made naturally in the body. It is made by: a gland in the brain (hypothalamus), the stomach, the pancreas and the bowel. Somatostatin can slow down hormone production, including many of the gut hormones, slows down the emptying of the stomach and bowel, controls the release of hormones made by the pancreas, including insulin and, slows down or stops the release of growth hormones. Rise in the research and development and launch of novel drug therapies are the factors driving the growth of somatostatin analogs over the forecast period.
The global Somatostatin Analogs market is valued at 2430 million US$ in 2018 and will reach 3580 million US$ by the end of 2025, growing at a CAGR of 5.0% during 2019-2025. The objectives of this study are to define, segment, and project the size of the Somatostatin Analogs market based on company, product type, end user and key regions.

This report studies the global market size of Somatostatin Analogs in key regions like North America, Europe, Asia Pacific, Central & South America and Middle East & Africa, focuses on the consumption of Somatostatin Analogs in these regions.
This research report categorizes the global Somatostatin Analogs market by top players/brands, region, type and end user. This report also studies the global Somatostatin Analogs market status, competition landscape, market share, growth rate, future trends, market drivers, opportunities and challenges, sales channels and distributors.

The following manufacturers are covered in this report, with sales, revenue, market share for each company:
Novartis
Peptron
Chiasma
Ipsen Biopharmaceutical

Market size by Product
Octreotide
Lanreotide
Pasireotide
Market size by End User
Acromegaly
Carcinoid Syndrome
Neuroendocrine Tumor
Cushing Syndrome
Others

Market size by Region
North America
United States
Canada
Mexico
Asia-Pacific
China
India
Japan
South Korea
Australia
Indonesia
Singapore
Malaysia
Philippines
Thailand
Vietnam
Europe
Germany
France
UK
Italy
Spain
Russia
Central & South America
Brazil
Rest of Central & South America
Middle East & Africa
GCC Countries
Turkey
Egypt
South Africa

The study objectives of this report are:
To study and analyze the global Somatostatin Analogs market size (value & volume) by company, key regions, products and end user, breakdown data from 2014 to 2018, and forecast to 2025.
To understand the structure of Somatostatin Analogs market by identifying its various subsegments.
To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
Focuses on the key global Somatostatin Analogs companies, to define, describe and analyze the sales volume, value, market share, market competition landscape and recent development.
To project the value and sales volume of Somatostatin Analogs submarkets, with respect to key regions.
To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

In this study, the years considered to estimate the market size of Somatostatin Analogs are as follows:
History Year: 2014-2018
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025

This report includes the estimation of market size for value (million US$) and volume (K MT). Both top-down and bottom-up approaches have been used to estimate and validate the market size of Somatostatin Analogs market, to estimate the size of various other dependent submarkets in the overall market. Key players in the market have been identified through secondary research, and their market shares have been determined through primary and secondary research. All percentage shares, splits, and breakdowns have been determined using secondary sources and verified primary sources.

For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

レポート目次

Table of Contents

1 Study Coverage
1.1 Somatostatin Analogs Product
1.2 Market Segments
1.3 Key Manufacturers Covered
1.4 Market by Type
1.4.1 Global Somatostatin Analogs Market Size Growth Rate by Product
1.4.2 Octreotide
1.4.3 Lanreotide
1.4.4 Pasireotide
1.5 Market by End User
1.5.1 Global Somatostatin Analogs Market Size Growth Rate by End User
1.5.2 Acromegaly
1.5.3 Carcinoid Syndrome
1.5.4 Neuroendocrine Tumor
1.5.5 Cushing Syndrome
1.5.6 Others
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Global Somatostatin Analogs Market Size
2.1.1 Global Somatostatin Analogs Revenue 2014-2025
2.1.2 Global Somatostatin Analogs Sales 2014-2025
2.2 Somatostatin Analogs Growth Rate by Regions
2.2.1 Global Somatostatin Analogs Sales by Regions
2.2.2 Global Somatostatin Analogs Revenue by Regions

3 Breakdown Data by Manufacturers
3.1 Somatostatin Analogs Sales by Manufacturers
3.1.1 Somatostatin Analogs Sales by Manufacturers
3.1.2 Somatostatin Analogs Sales Market Share by Manufacturers
3.1.3 Global Somatostatin Analogs Market Concentration Ratio (CR5 and HHI)
3.2 Somatostatin Analogs Revenue by Manufacturers
3.2.1 Somatostatin Analogs Revenue by Manufacturers (2014-2019)
3.2.2 Somatostatin Analogs Revenue Share by Manufacturers (2014-2019)
3.3 Somatostatin Analogs Price by Manufacturers
3.4 Somatostatin Analogs Manufacturing Base Distribution, Product Types
3.4.1 Somatostatin Analogs Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers Somatostatin Analogs Product Type
3.4.3 Date of International Manufacturers Enter into Somatostatin Analogs Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Product
4.1 Global Somatostatin Analogs Sales by Product
4.2 Global Somatostatin Analogs Revenue by Product
4.3 Somatostatin Analogs Price by Product

5 Breakdown Data by End User
5.1 Overview
5.2 Global Somatostatin Analogs Breakdown Data by End User

6 North America
6.1 North America Somatostatin Analogs by Countries
6.1.1 North America Somatostatin Analogs Sales by Countries
6.1.2 North America Somatostatin Analogs Revenue by Countries
6.1.3 United States
6.1.4 Canada
6.1.5 Mexico
6.2 North America Somatostatin Analogs by Product
6.3 North America Somatostatin Analogs by End User

7 Europe
7.1 Europe Somatostatin Analogs by Countries
7.1.1 Europe Somatostatin Analogs Sales by Countries
7.1.2 Europe Somatostatin Analogs Revenue by Countries
7.1.3 Germany
7.1.4 France
7.1.5 UK
7.1.6 Italy
7.1.7 Russia
7.2 Europe Somatostatin Analogs by Product
7.3 Europe Somatostatin Analogs by End User

8 Asia Pacific
8.1 Asia Pacific Somatostatin Analogs by Countries
8.1.1 Asia Pacific Somatostatin Analogs Sales by Countries
8.1.2 Asia Pacific Somatostatin Analogs Revenue by Countries
8.1.3 China
8.1.4 Japan
8.1.5 Korea
8.1.6 India
8.1.7 Australia
8.1.8 Indonesia
8.1.9 Malaysia
8.1.10 Philippines
8.1.11 Thailand
8.1.12 Vietnam
8.1.13 Singapore
8.2 Asia Pacific Somatostatin Analogs by Product
8.3 Asia Pacific Somatostatin Analogs by End User

9 Central & South America
9.1 Central & South America Somatostatin Analogs by Countries
9.1.1 Central & South America Somatostatin Analogs Sales by Countries
9.1.2 Central & South America Somatostatin Analogs Revenue by Countries
9.1.3 Brazil
9.2 Central & South America Somatostatin Analogs by Product
9.3 Central & South America Somatostatin Analogs by End User

10 Middle East and Africa
10.1 Middle East and Africa Somatostatin Analogs by Countries
10.1.1 Middle East and Africa Somatostatin Analogs Sales by Countries
10.1.2 Middle East and Africa Somatostatin Analogs Revenue by Countries
10.1.3 GCC Countries
10.1.4 Turkey
10.1.5 Egypt
10.1.6 South Africa
10.2 Middle East and Africa Somatostatin Analogs by Product
10.3 Middle East and Africa Somatostatin Analogs by End User

11 Company Profiles
11.1 Novartis
11.1.1 Novartis Company Details
11.1.2 Company Business Overview
11.1.3 Novartis Somatostatin Analogs Sales, Revenue and Gross Margin (2014-2019)
11.1.4 Novartis Somatostatin Analogs Products Offered
11.1.5 Novartis Recent Development
11.2 Peptron
11.2.1 Peptron Company Details
11.2.2 Company Business Overview
11.2.3 Peptron Somatostatin Analogs Sales, Revenue and Gross Margin (2014-2019)
11.2.4 Peptron Somatostatin Analogs Products Offered
11.2.5 Peptron Recent Development
11.3 Chiasma
11.3.1 Chiasma Company Details
11.3.2 Company Business Overview
11.3.3 Chiasma Somatostatin Analogs Sales, Revenue and Gross Margin (2014-2019)
11.3.4 Chiasma Somatostatin Analogs Products Offered
11.3.5 Chiasma Recent Development
11.4 Ipsen Biopharmaceutical
11.4.1 Ipsen Biopharmaceutical Company Details
11.4.2 Company Business Overview
11.4.3 Ipsen Biopharmaceutical Somatostatin Analogs Sales, Revenue and Gross Margin (2014-2019)
11.4.4 Ipsen Biopharmaceutical Somatostatin Analogs Products Offered
11.4.5 Ipsen Biopharmaceutical Recent Development

12 Future Forecast
12.1 Somatostatin Analogs Market Forecast by Regions
12.1.1 Global Somatostatin Analogs Sales Forecast by Regions 2019-2025
12.1.2 Global Somatostatin Analogs Revenue Forecast by Regions 2019-2025
12.2 Somatostatin Analogs Market Forecast by Product
12.2.1 Global Somatostatin Analogs Sales Forecast by Product 2019-2025
12.2.2 Global Somatostatin Analogs Revenue Forecast by Product 2019-2025
12.3 Somatostatin Analogs Market Forecast by End User
12.4 North America Somatostatin Analogs Forecast
12.5 Europe Somatostatin Analogs Forecast
12.6 Asia Pacific Somatostatin Analogs Forecast
12.7 Central & South America Somatostatin Analogs Forecast
12.8 Middle East and Africa Somatostatin Analogs Forecast

13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 Market Opportunities and Drivers
13.2 Market Challenges
13.3 Market Risks/Restraints
13.4 Macroscopic Indicators

14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 Somatostatin Analogs Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors

15 Research Findings and Conclusion

16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer

List of Tables and Figures

Figure Somatostatin Analogs Product Picture
Table Somatostatin Analogs Market Segments
Table Key Manufacturers Somatostatin Analogs Covered
Table Global Somatostatin Analogs Market Size Growth Rate by Product 2019-2025 (K MT) & (Million US$)
Figure Global Somatostatin Analogs Sales Market Share by Product 2014-2025
Figure Octreotide Product Picture
Table Major Manufacturers of Octreotide
Figure Lanreotide Product Picture
Table Major Manufacturers of Lanreotide
Figure Pasireotide Product Picture
Table Major Manufacturers of Pasireotide
Table Global Somatostatin Analogs Market Size Growth Rate by End User 2019-2025 (K MT)
Figure Acromegaly
Figure Carcinoid Syndrome
Figure Neuroendocrine Tumor
Figure Cushing Syndrome
Figure Others
Figure Somatostatin Analogs Report Years Considered
Figure Global Somatostatin Analogs Market Size 2014-2025 (Million US$)
Figure Global Somatostatin Analogs Sales 2014-2025 (K MT)
Table Global Somatostatin Analogs Market Size by Regions 2014-2019 (K MT) & (Million US$)
Table Global Somatostatin Analogs Sales by Regions 2014-2019 (K MT)
Table Global Somatostatin Analogs Sales Market Share by Regions 2014-2019
Figure Global Somatostatin Analogs Sales Market Share by Regions 2014-2019
Figure 2018 Global Somatostatin Analogs Sales Market Share by Regions
Table Global Somatostatin Analogs Revenue by Regions 2014-2019 (Million US$)
Table Global Somatostatin Analogs Revenue Market Share by Regions 2014-2019
Figure Global Somatostatin Analogs Revenue Market Share by Regions 2014-2019
Figure 2018 Global Somatostatin Analogs Revenue Market Share by Regions
Table Global Somatostatin Analogs Sales by Manufacturers (2014-2019) (K MT)
Table Global Somatostatin Analogs Sales Share by Manufacturers (2014-2019)
Figure Global Somatostatin Analogs Sales Share by Manufacturers in 2018
Table Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table Somatostatin Analogs Revenue by Manufacturers (2014-2019) (Million USD)
Table Somatostatin Analogs Revenue Share by Manufacturers (2014-2019)
Figure Somatostatin Analogs Value Share by Manufacturers in 2018
Table Key Manufacturers Somatostatin Analogs Price (2014-2019) (USD/MT)
Table Somatostatin Analogs Manufacturers Manufacturing Base Distribution and Headquarters
Table Manufacturers Somatostatin Analogs Product Type
Table Date of International Manufacturers Enter into Somatostatin Analogs Market
Table Manufacturers Mergers & Acquisitions, Expansion Plans
Table Global Somatostatin Analogs Sales by Product (2014-2019) (K MT)
Table Global Somatostatin Analogs Sales Share by Product (2014-2019)
Figure Global Somatostatin Analogs Sales Market Share by Product (2014-2019)
Figure Global Somatostatin Analogs Sales Market Share by Product in 2018
Table Global Somatostatin Analogs Revenue by Product (2014-2019) (Million US$)
Table Global Somatostatin Analogs Revenue Share by Product (2014-2019)
Figure Global Somatostatin Analogs Revenue Market Share by Product (2014-2019)
Figure Global Somatostatin Analogs Revenue Market Share by Product in 2018
Table Somatostatin Analogs Price by Product 2014-2019 (USD/MT)
Table Global Somatostatin Analogs Sales by End User (2014-2019) (K MT)
Table Global Somatostatin Analogs Sales Share by End User (2014-2019)
Figure Global Sales Somatostatin Analogs Market Share by End User (2014-2019)
Figure Global Sales Somatostatin Analogs Market Share by End User in 2018
Figure North America Somatostatin Analogs Sales Growth Rate 2014-2019 (K MT)
Figure North America Somatostatin Analogs Revenue Growth Rate 2014-2019 (Million US$)
Table North America Somatostatin Analogs Sales by Countries (2014-2019) (K MT)
Table North America Somatostatin Analogs Sales Market Share by Countries (2014-2019)
Figure 2018 North America Somatostatin Analogs Sales Market Share by Countries
Table North America Somatostatin Analogs Revenue by Countries (2014-2019) (Million US$)
Table North America Somatostatin Analogs Revenue Market Share by Countries (2014-2019)
Figure 2018 North America Somatostatin Analogs Revenue Market Share by Countries
Figure United States Somatostatin Analogs Sales Growth Rate (2014-2019) (K MT)
Figure United States Somatostatin Analogs Revenue Growth Rate (2014-2019) (K MT)
Figure Canada Somatostatin Analogs Sales Growth Rate (2014-2019) (K MT)
Figure Canada Somatostatin Analogs Revenue Growth Rate (2014-2019) (Million US$)
Figure Mexico Somatostatin Analogs Sales Growth Rate (2014-2019) (K MT)
Figure Mexico Somatostatin Analogs Revenue Growth Rate (2014-2019) (Million US$)
Table North America Somatostatin Analogs Sales by Product (2014-2019) (K MT)
Table North America Somatostatin Analogs Sales Market Share by Product (2014-2019)
Figure 2018 North America Somatostatin Analogs Market Share by Product
Table North America Somatostatin Analogs Sales by End User (2014-2019) (K MT)
Table North America Somatostatin Analogs Sales Market Share by End User (2014-2019)
Figure 2018 North America Somatostatin Analogs Market Share by End User
Figure Europe Somatostatin Analogs Sales Growth Rate 2014-2019 (K MT)
Figure Europe Somatostatin Analogs Revenue Growth Rate 2014-2019 (Million US$)
Table Europe Somatostatin Analogs Sales by Countries (2014-2019) (K MT)
Table Europe Somatostatin Analogs Sales Market Share by Countries (2014-2019)
Figure 2018 Europe Somatostatin Analogs Sales Market Share by Countries
Table Europe Somatostatin Analogs Revenue by Countries (2014-2019) (Million US$)
Table Europe Somatostatin Analogs Revenue Market Share by Countries (2014-2019)
Figure 2018 Europe Somatostatin Analogs Revenue Market Share by Countries
Figure Germany Somatostatin Analogs Sales Growth Rate (2014-2019) (K MT)
Figure Germany Somatostatin Analogs Revenue Growth Rate (2014-2019) (Million US$)
Figure France Somatostatin Analogs Sales Growth Rate (2014-2019) (K MT)
Figure France Somatostatin Analogs Revenue Growth Rate (2014-2019) (Million US$)
Figure UK Somatostatin Analogs Sales Growth Rate (2014-2019) (K MT)
Figure UK Somatostatin Analogs Revenue Growth Rate (2014-2019) (Million US$)
Figure Italy Somatostatin Analogs Sales Growth Rate (2014-2019) (K MT)
Figure Italy Somatostatin Analogs Revenue Growth Rate (2014-2019) (Million US$)
Figure Russia Somatostatin Analogs Sales Growth Rate (2014-2019) (K MT)
Figure Russia Somatostatin Analogs Revenue Growth Rate (2014-2019) (Million US$)
Table Europe Somatostatin Analogs Sales by Product (2014-2019) (K MT)
Table Europe Somatostatin Analogs Sales Market Share by Product (2014-2019)
Figure 2018 Europe Somatostatin Analogs Market Share by Product
Table Europe Somatostatin Analogs Sales by End User (2014-2019) (K MT)
Table Europe Somatostatin Analogs Sales Market Share by End User (2014-2019)
Figure 2018 Europe Somatostatin Analogs Market Share by End User
Figure Asia Pacific Somatostatin Analogs Sales Growth Rate 2014-2019 (K MT)
Figure Asia Pacific Somatostatin Analogs Revenue Growth Rate 2014-2019 (Million US$)
Table Asia Pacific Somatostatin Analogs Sales by Countries (2014-2019) (K MT)
Table Asia Pacific Somatostatin Analogs Sales Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Somatostatin Analogs Sales Market Share by Countries
Table Asia Pacific Somatostatin Analogs Revenue by Countries (2014-2019) (Million US$)
Table Asia Pacific Somatostatin Analogs Revenue Market Share by Countries (2014-2019)
Figure 2018 Asia Pacific Somatostatin Analogs Revenue Market Share by Countries
Figure China Somatostatin Analogs Sales Growth Rate (2014-2019) (K MT)
Figure China Somatostatin Analogs Revenue Growth Rate (2014-2019) (Million US$)
Figure Japan Somatostatin Analogs Sales Growth Rate (2014-2019) (K MT)
Figure Japan Somatostatin Analogs Revenue Growth Rate (2014-2019) (Million US$)
Figure Korea Somatostatin Analogs Sales Growth Rate (2014-2019) (K MT)
Figure Korea Somatostatin Analogs Revenue Growth Rate (2014-2019) (Million US$)
Figure India Somatostatin Analogs Sales Growth Rate (2014-2019) (K MT)
Figure India Somatostatin Analogs Revenue Growth Rate (2014-2019) (Million US$)
Figure Australia Somatostatin Analogs Sales Growth Rate (2014-2019) (K MT)
Figure Australia Somatostatin Analogs Revenue Growth Rate (2014-2019) (Million US$)
Figure Indonesia Somatostatin Analogs Sales Growth Rate (2014-2019) (K MT)
Figure Indonesia Somatostatin Analogs Revenue Growth Rate (2014-2019) (Million US$)
Figure Malaysia Somatostatin Analogs Sales Growth Rate (2014-2019) (K MT)
Figure Malaysia Somatostatin Analogs Revenue Growth Rate (2014-2019) (Million US$)
Figure Philippines Somatostatin Analogs Sales Growth Rate (2014-2019) (K MT)
Figure Philippines Somatostatin Analogs Revenue Growth Rate (2014-2019) (Million US$)
Figure Thailand Somatostatin Analogs Sales Growth Rate (2014-2019) (K MT)
Figure Thailand Somatostatin Analogs Revenue Growth Rate (2014-2019) (Million US$)
Figure Vietnam Somatostatin Analogs Sales Growth Rate (2014-2019) (K MT)
Figure Vietnam Somatostatin Analogs Revenue Growth Rate (2014-2019) (Million US$)
Figure Singapore Somatostatin Analogs Sales Growth Rate (2014-2019) (K MT)
Figure Singapore Somatostatin Analogs Revenue Growth Rate (2014-2019) (Million US$)
Table Asia Pacific Somatostatin Analogs Sales by Product (2014-2019) (K MT)
Table Asia Pacific Somatostatin Analogs Sales Market Share by Product (2014-2019)
Figure 2018 Asia Pacific Somatostatin Analogs Market Share by Product
Table Asia Pacific Somatostatin Analogs Sales by End User (2014-2019) (K MT)
Table Asia Pacific Somatostatin Analogs Sales Market Share by End User (2014-2019)
Figure 2018 Asia Pacific Somatostatin Analogs Market Share by End User
Figure Central & South America Somatostatin Analogs Sales Growth Rate 2014-2019 (K MT)
Figure Central & South America Somatostatin Analogs Revenue Growth Rate 2014-2019 (Million US$)
Table Central & South America Somatostatin Analogs Sales by Countries (2014-2019) (K MT)
Table Central & South America Somatostatin Analogs Sales Market Share by Countries (2014-2019)
Figure 2018 Central & South America Somatostatin Analogs Sales Market Share by Countries
Table Central & South America Somatostatin Analogs Revenue by Countries (2014-2019) (Million US$)
Table Central & South America Somatostatin Analogs Revenue Market Share by Countries (2014-2019)
Figure 2018 Central & South America Somatostatin Analogs Revenue Market Share by Countries
Figure Brazil Somatostatin Analogs Sales Growth Rate (2014-2019) (K MT)
Figure Brazil Somatostatin Analogs Revenue Growth Rate (2014-2019) (Million US$)
Figure Argentina Somatostatin Analogs Sales Growth Rate (2014-2019) (K MT)
Figure Argentina Somatostatin Analogs Revenue Growth Rate (2014-2019) (Million US$)
Table Central & South America Somatostatin Analogs Sales by Product (2014-2019) (K MT)
Table Central & South America Somatostatin Analogs Sales Market Share by Product (2014-2019)
Figure 2018 Central & South America Somatostatin Analogs Market Share by Product
Table Central & South America Somatostatin Analogs Sales by End User (2014-2019) (K MT)
Table Central & South America Somatostatin Analogs Sales Market Share by End User (2014-2019)
Figure 2018 Central & South America Somatostatin Analogs Market Share by End User
Figure Middle East and Africa Somatostatin Analogs Sales Growth Rate 2014-2019 (K MT)
Figure Middle East and Africa Somatostatin Analogs Revenue Growth Rate 2014-2019 (Million US$)
Table Middle East and Africa Somatostatin Analogs Sales by Countries (2014-2019) (K MT)
Table Middle East and Africa Somatostatin Analogs Sales Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Somatostatin Analogs Sales Market Share by Countries
Table Middle East and Africa Somatostatin Analogs Revenue by Countries (2014-2019) (Million US$)
Table Middle East and Africa Somatostatin Analogs Revenue Market Share by Countries (2014-2019)
Figure 2018 Middle East and Africa Somatostatin Analogs Revenue Market Share by Countries
Figure GCC Countries Somatostatin Analogs Sales Growth Rate (2014-2019) (K MT)
Figure GCC Countries Somatostatin Analogs Revenue Growth Rate (2014-2019) (Million US$)
Figure Turkey Somatostatin Analogs Sales Growth Rate (2014-2019) (K MT)
Figure Turkey Somatostatin Analogs Revenue Growth Rate (2014-2019) (Million US$)
Figure Egypt Somatostatin Analogs Sales Growth Rate (2014-2019) (K MT)
Figure Egypt Somatostatin Analogs Revenue Growth Rate (2014-2019) (Million US$)
Figure South Africa Somatostatin Analogs Sales Growth Rate (2014-2019) (K MT)
Figure South Africa Somatostatin Analogs Revenue Growth Rate (2014-2019) (Million US$)
Table Middle East and Africa Somatostatin Analogs Sales by Product (2014-2019) (K MT)
Table Middle East and Africa Somatostatin Analogs Sales Market Share by Product (2014-2019)
Figure 2018 Middle East and Africa Somatostatin Analogs Market Share by Product
Table Middle East and Africa Somatostatin Analogs Sales by End User (2014-2019) (K MT)
Table Middle East and Africa Somatostatin Analogs Sales Market Share by End User (2014-2019)
Figure 2018 Middle East and Africa Somatostatin Analogs Market Share by End User
Table Novartis Company Details
Table Novartis Somatostatin Analogs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Novartis Recent Development

Table Peptron Company Details
Table Peptron Somatostatin Analogs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Peptron Recent Development

Table Chiasma Company Details
Table Chiasma Somatostatin Analogs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Chiasma Recent Development

Table Ipsen Biopharmaceutical Company Details
Table Ipsen Biopharmaceutical Somatostatin Analogs Sales (K MT), Revenue (Million USD), Price (USD/MT) and Gross Margin (2014-2019)
Table Ipsen Biopharmaceutical Recent Development

Table Global Somatostatin Analogs Sales Forecast by Regions 2019-2025 (K MT)
Table Global Somatostatin Analogs Sales Market Share Forecast by Regions 2019-2025
Table Global Somatostatin Analogs Revenue Forecast by Regions 2019-2025 (Million US$)
Table Global Somatostatin Analogs Revenue Market Share Forecast by Regions 2019-2025
Table Global Somatostatin Analogs Sales Forecast by Product 2019-2025 (K MT)
Table Global Somatostatin Analogs Sales Market Share Forecast by Product 2019-2025
Table Global Somatostatin Analogs Revenue Forecast by Product 2019-2025 (Million US$)
Table Global Somatostatin Analogs Revenue Market Share Forecast by Product 2019-2025
Table Global Somatostatin Analogs Sales Forecast by End User 2019-2025 (K MT)
Table Global Somatostatin Analogs Sales Market Share Forecast by End User 2019-2025
Figure North America Somatostatin Analogs Sales Growth Rate Forecast (2019-2025) (K MT)
Figure North America Somatostatin Analogs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Europe Somatostatin Analogs Sales Growth Rate Forecast (2019-2025) (K MT)
Figure Europe Somatostatin Analogs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Asia Pacific Somatostatin Analogs Sales Growth Rate Forecast (2019-2025) (K MT)
Figure Asia Pacific Somatostatin Analogs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Central & South America Somatostatin Analogs Sales Growth Rate Forecast (2019-2025) (K MT)
Figure Central & South America Somatostatin Analogs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Figure Middle East and Africa Somatostatin Analogs Sales Growth Rate Forecast (2019-2025) (K MT)
Figure Middle East and Africa Somatostatin Analogs Revenue Growth Rate Forecast (2019-2025) (Million US$)
Table Somatostatin Analogs Value Chain
Table Somatostatin Analogs Customers List
Table Somatostatin Analogs Distributors List
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources